The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of smoking on immunotherapy outcomes in gastric, gastro-esophageal junction, and esophageal cancers (G/GEJ/EC): A real-world analysis.
 
Nadia Ghazali
No Relationships to Disclose
 
Hiroko Aoyama
No Relationships to Disclose
 
Yvonne Bach
No Relationships to Disclose
 
Katherine Lajkosz
No Relationships to Disclose
 
Sokaina Akhtar
No Relationships to Disclose
 
Alana St Bernard
No Relationships to Disclose
 
Yahan Yang
No Relationships to Disclose
 
Ronan McLaughlin
No Relationships to Disclose
 
Rich Ericson King
No Relationships to Disclose
 
Lawson Eng
No Relationships to Disclose
 
Raymond Jang
Consulting or Advisory Role - Merck
Research Funding - AstraZeneca (Inst); Camurus (Inst); Merck (Inst)
 
Eric Chen
Honoraria - AstraZeneca Canada; Eisai; GlaxoSmithKline; Merck; Pfizer; Roche; Takeda
Research Funding - 1Globe Health Institute; AstraZeneca/MedImmune; Bristol-Myers Squibb; GlaxoSmithKline; Janssen Oncology; Merck Sharp & Dohme; Mirati Therapeutics; Novartis; Repare Therapeutics; Roche Canada
 
Carly Barron
No Relationships to Disclose
 
Lucy Ma
No Relationships to Disclose
 
Jonathan Yeung
No Relationships to Disclose
 
Elliot Wakeam
No Relationships to Disclose
 
Aruz Mesci
No Relationships to Disclose
 
Sangeetha Kalimuthu
No Relationships to Disclose
 
Rebecca Wong
No Relationships to Disclose
 
Elena Elimova
Employment - Merck (I)
Honoraria - Daiichi Sankyo/Astra Zeneca; Roche Canada
Consulting or Advisory Role - Abbvie; Adaptimmune (Inst); Astellas Pharma; AstraZeneca; BeiGene; Bristol-Myers Squibb (Inst); Jazz Pharmaceuticals (Inst); Signatera; Viracta Therapeutics; Zymeworks (Inst)
Research Funding - Amgen (Inst); Arcus Biosciences (Inst); AstraZeneca Canada (Inst); Bold Therapeutics (Inst); Bristol-Myers Squibb (Inst); Jazz Pharmaceuticals (Inst); Jazz Pharmaceuticals (Inst); Zymeworks (Inst)